Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lund

Showing results (481-490 of 1,009) with videos related to

Pageof 101
Sort By:
ESC Heart Failure|February 19, 2026
Novel biomarkers distinguish heart failure with preserved vs reduced ejection fractionCamilla Hage, Annika Mang, Jean Claude Daubert, et al.
International Journal of Cardiology|May 11, 2026
Total NT-proBNP in heart failure with preserved vs reduced ejection fractionCamilla Hage, Anika Mang, Jean Claude Daubert, et al.
Basic & Clinical Pharmacology & Toxicology|December 25, 2019
Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancerÓskar Ö Hálfdánarson, Anton Pottegård, Sigrún H Lund, et al.
Nucleic Acids Research|June 20, 2015
Transcriptome dynamics of the microRNA inhibition responseJiayu Wen, Eleonora Leucci, Roberto Vendramin, et al.
The International Journal of Cardiovascular Imaging|June 19, 2021
Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic databaseAshwin Venkateshvaran, Natavan Seidova, Hande Oktay Tureli, et al.
ESC Heart Failure|June 18, 2019
Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fractionUlrika Löfström, Camilla Hage, Gianluigi Savarese, et al.
Chest|March 13, 2001
Positron emission tomography in the staging of small-cell lung cancer : a preliminary studyH P Hauber, K H Bohuslavizki, C H Lund, et al.
Open Heart|August 2, 2017
Comparison of the Chronic Kidney Disease Epidemiology Collaboration, the Modification of Diet in Renal Disease study and the Cockcroft-Gault equation in patients with heart failureKarolina Szummer, Marie Evans, Juan Jesus Carrero, et al.
Cardiovascular Drugs and Therapy|March 24, 2019
"Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure RegistryJoanne Simpson, L Benson, P S Jhund, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 5, 2018
Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective StudyChris J Kapelios, Maria Bonou, Paraskevi Vogiatzi, et al.
Pageof 101

Showing results (481-490 of 1,009) with videos related to

Sort By:
Pageof 101
ESC Heart Failure|February 19, 2026
Novel biomarkers distinguish heart failure with preserved vs reduced ejection fractionCamilla Hage, Annika Mang, Jean Claude Daubert, et al.
International Journal of Cardiology|May 11, 2026
Total NT-proBNP in heart failure with preserved vs reduced ejection fractionCamilla Hage, Anika Mang, Jean Claude Daubert, et al.
Basic & Clinical Pharmacology & Toxicology|December 25, 2019
Use of proton pump inhibitors and mortality among Icelandic patients with prostate cancerÓskar Ö Hálfdánarson, Anton Pottegård, Sigrún H Lund, et al.
Nucleic Acids Research|June 20, 2015
Transcriptome dynamics of the microRNA inhibition responseJiayu Wen, Eleonora Leucci, Roberto Vendramin, et al.
The International Journal of Cardiovascular Imaging|June 19, 2021
Accuracy of echocardiographic estimates of pulmonary artery pressures in pulmonary hypertension: insights from the KARUM hemodynamic databaseAshwin Venkateshvaran, Natavan Seidova, Hande Oktay Tureli, et al.
ESC Heart Failure|June 18, 2019
Prognostic impact of Framingham heart failure criteria in heart failure with preserved ejection fractionUlrika Löfström, Camilla Hage, Gianluigi Savarese, et al.
Chest|March 13, 2001
Positron emission tomography in the staging of small-cell lung cancer : a preliminary studyH P Hauber, K H Bohuslavizki, C H Lund, et al.
Open Heart|August 2, 2017
Comparison of the Chronic Kidney Disease Epidemiology Collaboration, the Modification of Diet in Renal Disease study and the Cockcroft-Gault equation in patients with heart failureKarolina Szummer, Marie Evans, Juan Jesus Carrero, et al.
Cardiovascular Drugs and Therapy|March 24, 2019
"Real World" Eligibility for Sacubitril/Valsartan in Unselected Heart Failure Patients: Data from the Swedish Heart Failure RegistryJoanne Simpson, L Benson, P S Jhund, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|July 5, 2018
Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective StudyChris J Kapelios, Maria Bonou, Paraskevi Vogiatzi, et al.
Pageof 101